Table 2.
Item | n (%) |
---|---|
Knowledge | |
HPV infection and HPV vaccinea | |
HPV increases risk for vaginal cancer | 13 (31.0) |
Most women with HPV infection are asymptomatic | 39 (95.1) |
HPV infection cause most cases of cervical cancer | 37 (92.5) |
HPV vaccine protects against 2 types of HPV | 39 (92.9) |
HPV vaccine may protect against vulvar cancer | 18 (42.9) |
HPV vaccine may help prevent penile cancer | 10 (24.4) |
Perceived effectiveness of screening testsb | |
HPV | 14 (46.7) |
VIA | 23 (57.5) |
Cytology | 12 (30.8) |
Familiar with the advantages of the self-collected HPV test | 7 (17.1) |
Attitudes on VIA and cryotherapy | |
Acceptability | |
Think patients would accept VIA and cryotherapyc | 41 (100.0) |
Think their colleagues would accept VIA and cryotherapy | 29 (70.7) |
Think VIA should replace the Pap test | 25 (61.0) |
Think VIA and cryotherapy would have an impact on other health services | 30 (75.0) |
Think performing VIA and cryotherapy in a single visit is not feasible in their specific health facility | 17 (41.5) |
3 main challenges to implement a single visit screen-and-treat approachd | |
Lack of equipment | 14 (87.5) |
Lack of capacity | 8 (50.0) |
Few health professionals in hospital/health center | 4 (25.0) |
Attitudes on HPV testing and HPV vaccine | |
Would recommend the HPV vaccine to female patients | 38 (92.7) |
Think incorporation of HPV testing is feasible within 5 years | 8 (42.1) |
Perceived barriers for early detection of cervical cancere | |
General barriers | |
Cultural | 31 (75.6) |
Political | 2 (5.0) |
Economic | 3 (7.5) |
Organizational | 4 (10.0) |
Specific barriersf | |
The taboo about Pap testing among women | 30 (71.4) |
Lack of educational campaigns and infrastructure | 22 (52.4) |
Lack of dissemination of screening guidelines | 17 (40.5) |
Lack of knowledge about cervical cancer | 16 (38.1) |
Lack of priority given to women’s health | 13 (31.0) |
Lack of infrastructure and organization of the Bolivian healthcare system | 12 (28.6) |
The belief that cancer cannot be prevented | 9 (21.4) |
The stigma related to cervical cancer for being a sexually transmitted illness | 6 (14.3) |
Level of awareness among patients about getting screened for cervical cancer | |
High | 2 (4.8) |
Moderate | 15 (35.7) |
Low | 22 (52.4) |
None | 3 (7.1) |
All items were asked at pretest except for those related to attitudes on specific procedures.
No. of correct responses.
No. of participants who reported that the test is very effective.
n = 41.
Participants were instructed to check all that apply. Only the most cited categories are presented.
Participants were given 4 barriers and asked to list them according to their level of importance in preventing early detection of cervical cancer.
Participants were asked to select 3 of the 8 barriers listed.
HPV, human papillomavirus; VIA, visual inspection with acetic acid.